Cargando…
Delineating the role of osteoprotegerin as a marker of breast cancer risk among women with a BRCA1 mutation
Women with a pathogenic germline mutation in the BRCA1 gene face a very high lifetime risk of developing breast cancer, estimated at 72% by age 80. Prophylactic bilateral mastectomy is the only effective way to lower their risk; however, most women with a mutation opt for intensive screening with an...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008947/ https://www.ncbi.nlm.nih.gov/pubmed/35418083 http://dx.doi.org/10.1186/s13053-022-00223-3 |